Resistance	Microbe	Outcome
Apramycin /	Salmonella spp.	See: Table 1 AMR+ (n) AMR- (n) Total (n) Apramycin use 21 89 No use 31 223
Carbadox /	Salmonella spp.	See: Table 1 AMR+ (n) AMR- (n) Total (n) Apramycin use 7 89 No use 0 223
Kanamycin /	Salmonella spp.	See: Table 1 AMR+ (n) AMR- (n) Total (n) Apramycin use 0 89 No use 10 223
Amikacin /	Salmonella spp.	See: Table 1 AMR+ (%) AMR- (%) Total (n) Apramycin use 0.00 100 No use 0.00 100
Streptomycin /	Salmonella spp.	See: Table 1 AMR+ (n) AMR- (n) Total (n) Apramycin use 63 89 No use 172 223
Gentamicin /	Salmonella spp.	See: Table 1 AMR+ (%) AMR- (%) Total (n) Apramycin use 0.00 100 No use 0.00 100